Caution about Newcastle disease virus-based live attenuated vaccine.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

1. Complete Genomic Characterization of Lumpy Skin Disease Virus Isolates from Beef Cattle in Lopburi Province, Central Thailand, during 2021-2022.Veterinary sciences · 2023
   Article
2. Avian Orthoavulavirus Type-1 as Vaccine Vector against Respiratory Viral Pathogens in Animal and Human.Vaccines · 2022
   Review
3. Newcastle Disease Virus as a Vaccine Vector for 20 Years: A Focus on Maternally Derived Antibody Interference.Vaccines · 2020
   Review
4. Analysis and insights into recombination signals in lumpy skin disease virus recovered in the field.PloS one · 2018
   Article
5. Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.Vaccine · 2016
   Review
6. Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.PloS one · 2013
   Article
7. Homologous recombination in negative sense RNA viruses.Viruses · 2011
   Review
8. Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.Human vaccines · 2010
   Review
9. What are the risks--hypothetical and observed--of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?Journal of virology · 2008
   Article
10. Not so fast on recombination analysis of Newcastle disease virus.Journal of virology · 2008
    Article

Corrections and comments

• Commented on by
  Not so fast on recombination analysis of Newcastle disease virus.2008
• Comment on
  Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.2006
• Comment on
  Nonsegmented negative-strand viruses as vaccine vectors.2006
• Comment on
  Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.2007
• Comment on
  Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.2007

Authors and funding

3 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as